Christina Jewett,

Christina Jewett covers the Food and Drug Administration (FDA) for The New York Times. She has a background in investigative reporting and her work has been recognized with awards such as George Polk Award, James Batten Medal and Barlett & Steele gold award. Her coverage focuses on medications, food safety, medical devices, tobacco policy.

Biography: https://www.nytimes.com/by/christina-jewett

76%

The Daily's Verdict

This author has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on the author's reporting.

Bias

85%

Examples:

Canada's drug supply is too small to meet the demands of both American and Canadian consumers.
Spikes of fatalities linked to drinking that began with the Covid pandemic were not an anomaly.

Conflicts of Interest

69%

Examples:

Dr. Michael Siegel is quoted stating that there has been a substantial increase in alcohol-related deaths over the last six years without providing any evidence to support this claim or disclosing his affiliation with Tufts University School of Medicine which could be seen as biased information.
Some drug manufacturers have agreements with Canadian wholesalers not to export their medicines
The pharmaceutical industry's major lobbying organization...is expected to file suit to prevent the Florida plan from going into effect

Contradictions

85%

Examples:

During that period (2016-2021), the deaths rose by 27 percent among men and 35 percent among women.
The whole thing is a jerry-rigged, complicated approach to a problem that's amenable to a pretty straightforward solution.

Deceptions

75%

Examples:

Dr. Robert Califf, the FDA commissioner said that these proposals must demonstrate they would result in significant cost savings to consumers without adding risk of exposure to unsafe or ineffective drugs.
The article mentions that some drug manufacturers have agreements with Canadian wholesalers not to export their medicines. This implies that these drugs will be available for purchase by individuals in the United States, but it is unclear if they will also be imported by states like Florida.